JOA - 2026-10-07 - Journal Article
Cemented Femoral Fixation for Primary Total Hip Arthroplasty in the United States: How Surgeon-Cemented Volume Impacts Failure Risk.
Abrolat JL, Zedan AM, Ahmadi A, Juels M, Taylor JM, Bini S, Diaz-Ledezma C
Topics
Key Takeaway
Surgeons performing fewer than 60 cemented THA stems over five years had 2.10x higher odds of all-cause revision at two years compared to higher-volume surgeons.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study asked whether surgeon-specific cemented femoral stem volume affects revision risk in primary THA using a national database of cemented THAs from 2016–2020. Surgeons were dichotomized at a 5-year volume threshold of 60 stems and 7,174 propensity-matched patients were analyzed. Low-volume surgeons (<60 stems) had significantly higher 2-year rates of all-cause revision (OR 2.10), dislocation (OR 2.51), loosening (OR 2.21), PJI (OR 2.19), and periprosthetic fracture (OR 1.58), with Kaplan-Meier divergence occurring within the first postoperative year.
Key Limitation
The binary volume threshold of 60 stems over 5 years is investigator-defined without dose-response analysis, making it impossible to determine whether a true minimum competency threshold exists or whether outcomes improve continuously with increasing volume.
Original Abstract
BACKGROUND
Although cementless femoral fixation remains the United States (U.S.) standard, recent data shows a decline in exclusive cementless usage from 34 to 14% between 2018 and 2024. Whether surgeon-cemented total hip arthroplasty (THA) volume affects implant survivorship remains unclear in this traditionally low-volume environment. As such, we evaluated the association between surgeon cemented stem volume and risk of all-cause revision.
METHODS
This retrospective cohort study used a national database to identify primary THAs with cemented femoral fixation from 2016 to 2020. Surgeons were classified by their five-year cemented stem volume: Group 1 (less than 60 stems) or Group 2 (≥ 60 stems). Patients had a minimum two-year follow-up and were propensity score-matched 1:1 based on demographics and comorbidities. A total of 7,174 matched patients were analyzed (3,587 per cohort). Outcomes were all-cause revision, periprosthetic fracture (PPF), mechanical loosening, periprosthetic joint infection (PJI), and dislocation within five years.
RESULTS
Patients treated by Group 1 surgeons had higher rates of all study outcomes. At two years, Group 1 patients had higher odds of all-cause revision (odds ratio (OR) = 2.10; 95% confidence interval: 1.44 to 3.11; P < 0.001). Kaplan-Meier analysis showed revision risk diverged sharply within the first postoperative year and persisted through five years. At two-year follow-up, Group 1 patients had increased risk of PPF (OR = 1.58; P = 0.038), loosening (OR = 2.21; P < 0.001), PJI (OR = 2.19; P < 0.001), and dislocation (OR = 2.51; P < 0.001).
CONCLUSIONS
Low surgeon cemented stem volume is strongly associated with increased risk of revision following cemented THA. While cemented femoral fixation remains a useful alternative for high-risk patients undergoing elective THA, the benefits may be compromised if the surgery is performed by surgeons whose specific volume for this type of fixation is low.